Cotinga Pharmaceuticals Inc COTQF

Healthcare Biotechnology

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.

GREY:COTQF - Post by User

Cotinga Pharmaceuticals Inc

<< Previous

Bullboard Posts

Next >>

Post by UberWealthon Jul 28, 2017 9:50am

134 Views

Post# 26520912

COT Share Questions

Tax loss season is coming up - does anyone have a gain on COT shares? Private Placement is coming up - is the company in a strong position? Market Cap is now miniscule - does that attract more or less interest? Volume has dried up - can you get in or out? In addition, management has hired 2 PR firms - one in the U.S. Is there any U.S. buying? Those firms were hired months ago but have been quiet. What does that mean? Why pay for firms to do nothing? Management has gone through enormous changes. Founder is gone. High paid CEO has come in. Stock at lows. This company has changed. Share price has changed too. Who is answering these questions?

<< Previous

Bullboard Posts

Next >>

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles